Homozygous Thyroid Hormone Receptor β-Gene Mutations in Resistance to Thyroid Hormone: Three New Cases and Review of the Literature
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
CONTEXT: The most common cause of resistance to thyroid hormone (RTH) is heterozygous thyroid hormone receptor β (THRB) gene mutations. Homozygous mutations in the THRB gene are a rare event. OBJECTIVE: In this study, the clinical findings of three new patients (belonging to two families) homozygous for mutations in the THRB gene are compared to three other families in which affected individuals lack a normal TRβ. METHODS: We conducted clinical studies and genetic analyses. RESULTS: The clinical presentation in all three homozygous subjects was unusually severe; their phenotype was characterized by compromised intellectual development, tachycardia, goiter, growth retardation, and hearing loss. This was comparable with one other reported patient homozygous for mutant TRβ, but not in RTH due to THRB gene deletions. CONCLUSION: We report three new subjects, from two families, in whom RTH was associated with homozygous mutations in the THRB gene. They represent an important addition to the single known patient homozygous for a mutant TRβ. The clinical and laboratory abnormalities indicate a strong dominant-negative effect and are in agreement with data obtained from mice expressing a mutant Thrb in both alleles. This report strengthens the concept that the mutated TRβ interferes with the function of the TRα1 in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, hypothyroidism is associated with a poor prognosis in established heart failure (33) and TH can reduce intrahepatic triglyceride content (34,35).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [34]
In the citing paper
“and TH can reduce intrahepatic triglyceride content [34, 35].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [34]
Citations
Cites
The Syndromes of Resistance to Thyroid Hormone*
REFETOFF, S., WEISS, R. E., & USALA, S. J. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-3-348 · Cited by 873
Self-citationREFETOFF, S., DEWIND, L. T., & DEGROOT, L. J. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-2-279 · Cited by 568
Self-citationForrest, D., Hanebuth, E., Smeyne, R. J., Everds, N., Stewart, C. L., Wehner, J. M., & Curran, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00664.x · Cited by 440
Thyroid hormone receptor β is essential for development of auditory function
Forrest, D., Erway, L. C., Ng, L., Altschuler, R., & Curran, T. (1996) · Nature Genetics · doi:10.1038/ng0796-354 · Cited by 371
Refetoff, S., & Dumitrescu, A. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.03.005 · Cited by 295
Self-citationBrucker-Davis, F., Skarulis, M. C., Grace, M. B., Benichou, J., Hauser, P., Wiggs, E., & Weintraub, B. D. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-8-199510150-00002 · Cited by 275
Kaneshige, M., Kaneshige, K., Zhu, X.-G., Dace, A., Garrett, L., Carter, T. A., Kazlauskaite, R., Pankratz, D. G., Wynshaw-Boris, A., Refetoff, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230285997 · Cited by 268
Self-citationCellular Action of Thyroid Hormone on the Heart
Dillmann, W. H. (2002) · Thyroid · doi:10.1089/105072502760143809 · Cited by 252
Parrilla, R., Mixson, A. J., McPherson, J. A., McClaskey, J. H., & Weintraub, B. D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115542 · Cited by 244
An unliganded thyroid hormone receptor causes severe neurological dysfunction
Hashimoto, K., Curty, F. H., Borges, P. P., Lee, C. E., Abel, E. D., Elmquist, J. K., Cohen, R. N., & Wondisford, F. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051454698 · Cited by 238
Cited by
Items 101–125 of 125
Syndromes of Resistance to Thyroid Hormone
Moran, C., Gurnell, M., & Chatterjee, K. (2022) · doi:10.1093/med/9780198870197.003.0071
Bai, X., Xu, K., Chen, S., Xie, L., Qiu, Y., & Sun, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1305245/v1
Thyroid Hormone Resistance: A Case Report
Almacan, B., Ozdemir, N. A., Gürkan, H., Gül, S. Ş., Güldiken, S., & Hekimsoy, Z. (2021) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2021.388
“Clinical findings in patients may show hypothyroidism, hyperthyroidism, learning disabilities, and hyperactivity according to the level of THRβ and THRα gene expression in the target tissue (3,5).”
BackgroundBai, X., Xu, K., Chen, S., Xie, L., Qiu, Y., & Sun, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1305245/v2
Schilddrüsenhormon-Rezeptor β-Genmutation
Bidlingmaier, M. (2018) · Springer eBooks · doi:10.1007/978-3-662-49054-9_2759-1
Manto, M. U., & Hampe, C. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-15070-8_91
de Carvalho, G. A., Miasaki, F. Y., Fighera, T. M., Watanabe, Y., & Weiss, R. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00007-8
Self-citationThyroid Hormone Resistance: A 17-Year Follow-up Case Report
Giusto, C., Passeri, M., Sperti, P., Nardone, I., Sellasie, S. W., Zaccaria, S., Longo, L., Deserto, P. L., Amendola, S., & Uccioli, L. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303329834240815193640
Thyroid gland: Anatomy and physiology
Benvenga, S., Tuccari, G., Ieni, A., Fallahi, P., & Famà, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00079-0
Pathophysiology and Mouse Models of Thyroid Hormone Resistance Syndromes: A Focus on the Brain
Bernal, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274226124010013
Thyroid Hormone Resistance Syndrome: A Case Report with Literature Review
Kela, G., Mostafa, H. A., Gazya, H., Ahmed, N., & Hassan, A. (2025) · ASIDE Case Reports · doi:10.71079/aside.cr.07222523
Resistência às hormonas tiroideias por mutação dos recetores hormonais
Barbosa, A. P. D. R. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/ysvm-gf54
Complex Genomic Regions Under Selection in Atlantic Herring Resolved by Long-Read Sequencing
Jamsandekar, M. (2023) · OakTrust (Texas A&M University Libraries)
(2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Thyroid hormone resistance syndrome: mechanisms and clinical manifestation
Deprá, I. D. C. [. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Identification of a novel THRB mutation causing thyroid hormone resistance syndrome
Yang, J., Wang, C., Li, Q., & Jiang, S. (2026) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2026-0006
Vargas, V. M., Dwivedi, S., & Penquite, S. A. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.02.010
Mise en oeuvre de dosages pour le diagnostic précoce de l'hypothyroïdie
Iss, C. (2015) · theses.fr (ABES) · doi:10.70675/f9f2aeebza5a8z4cf3zb9afzd52e7504b286
Solange, G., & Caron, P. J. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102548
A case of thyroid hormone resistance with coincidental pituitary macroadenoma
Pan, Y., Wang, L., Malabu, U. H., & Rangaswamaiah, S. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag051
“They typically have dysmorphic features such as bird-like facies, goiter, pectus cari-natum, stippled epiphyses, and developmental growth delay due to delayed bone maturation [4, 6, 7].”
Kolbaşı, B., Ünal, E., Durak, H., Akalın, A., Gider, T., Yıldırım, R., Özalkak, Ş., Karakaya, A. A., & Beştaş, A. (2026) · Endocrine · doi:10.1007/s12020-026-04680-x
“Furthermore, different tissues within the same patient may exhibit differing levels of resistance [10].”
Liao, W., Marelli, F., Moran, C., Campi, I., Groeneweg, S., Mohamed, Z., Kamaleldeen, E. B., Padidela, R., Olivius, C., Oosterkamp, L., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106512
“26,32 This suggests that for many mutants, their dominant negative inhibitory effect is incomplete, enabling residual wild-type receptor action to determine the HPT axis.”
de Carvalho, J. P. M. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Dubois, S. G., Savagner, F., Héneau, A., Azar-Kolakez, A., Al-Amir, I., & Carel, J. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag316
Metadata
- Authors
- Ferrara, A. M., Onigata, K., Ercan, O., Woodhead, H., Weiss, R. E., & Refetoff, S.
- Affiliations
- University of Chicago (US)
- Istanbul University-Cerrahpaşa (TR)
- Sydney Children's Hospital (AU)
- Corresponding author
- Refetoff, Samuel
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-04
- Volume
- 97
- Issue
- 4
- Pages
- 1328-1336
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3319181
- OpenAlex
- W2164383111
- Cited by
- 110
- References
- 33
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 16 · 2014: 10 · 2013: 11 · 2012: 4
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R37-DK 15070, P60DK20595, R37DK015070, P60DK020595)
- National Center for Research Resources (5M01RR04999)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid hormone resistance, thyroid hormone receptor beta, homozygous mutation, dominant negative effect, intellectual disability, tachycardia, goiter, growth retardation, hearing loss, thyroid hormone receptor alpha 1, familial case
- MeSH terms
- Child, Preschool, Female, Genes, Recessive, Homozygote, Humans, Infant, Newborn, Male, Mutation, Pedigree, Severity of Illness Index, Point Mutation, Thyroid Hormone Resistance Syndrome, Amino Acid Substitution, Thyroid Hormone Receptors beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.